GenAI Is Revolutionizing Pharmacy with Harry Travis and Steven Wardell

Pharmacy was based on pills, and PBMs were based on margins. GenAI challenges both.

The practice and business of pharmacy is one of the most, if not the most, data intense medical professions and therefore is more susceptible to disruptive AI than any other healthcare profession.

In this show we'll cover:

• How AI is freeing pharmacy operation teams from the tyranny of the screens.
• There are dozens of early-stage companies powered by AI tools that are working to automate or optimize every step in the process of filling a prescription and determining the appropriate insurance coverage.
• Over $1 billion dollars in capital has been invested in this space over the past three years.
• Drug companies are launching Direct to Consumer websites for their patented medicines. How do these work and will they provide better access for patients?
• Will Most Favored Nations pricing have an effect on drug prices

And we'll answer your questions.

Harry Travis is the President of The Travis Group. He provides strategic consulting and executive coaching services to both US-based and international clients in the pharmacy, digital medicine, and medical technology markets. He is also the founder of TheRxRoundtable.com, which is a network of expert advisors to the pharmacy and pharmacy technology space. Prior to founding The Travis Group, he was Senior Vice President, Member Services Operations at CVS Caremark. Harry also held senior leadership positions with Baxter Healthcare, Cardinal Health, Accredo/Medco, and Aetna, where he served as the VP of Aetna’s Specialty and Home-Delivery Pharmacy business.

Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.